Stock 2269 WUXI BIOLOGICS (CAYMAN) INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases WuXi Biologics (Cayman) Inc.

Equities

2269

KYG970081173

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:42 28/06/2024 BST 		5-day change 1st Jan Change
11.54 HKD -1.20% Intraday chart for WuXi Biologics (Cayman) Inc. -0.52% -61.01%
06-27 Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target is HK$14 MT
06-19 Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
WuXi Biologics Named to MSCI ESG Leaders Indexes for Second Consecutive Year
AQ
WuXi Biologics Cayman : Named to MSCI ESG Leaders Indexes for Second Consecutive Year
PU
WuXi Biologics Enhances Manufacturing Capability with the Installation of Three 5,000L Single-Use Bioreactors
AQ
WuXi facility boosts bioprocessing capacity with new bioreactors
AQ
WuXi Biologics Cayman : Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment
PU
WuXi Biologics Selected for S&P Global Sustainability Yearbook 2024
AQ
WuXi Biologics Wins 2024 CDMO Leadership Awards in All Categories
AQ
WuXi Biologics Reports Solid 2023 Annual Results
AQ
WuXi Biologics Named to CDP 'A List' for Water Security
AQ
WuXi Biologics Cayman : Breaks Ground on CRDMO Center in Singapore
PU
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
AQ
WuXi Biologics Ireland Site Receives Three ISO Certifications
AQ
WuXi Biologics achieves large-scale manufacturing milestone
AQ
WuXi Biologics Launches WuXiaADCC PLUSTM for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect
AQ
WuXi Biologics Granted U.S. Patent for Proprietary Bispecific Antibody Technology Platform WuXiBodyTM
AQ
WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates
AQ
WUXI BIOLOGICS TO PARTICIAPTE AT 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
AQ
WuXi Biologics to Increase Manufacturing Capacity in Massachusetts
AQ
WuXi Biologics Awarded Highest Platinum Medal by EcoVadis Sustainability Rating
AQ
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of 6 g/L/day at Pilot Scale
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2269 Stock
  4. News WuXi Biologics (Cayman) Inc.
  5. Press Releases